Bateman; Simon David
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bateman; Simon David.The latest application filed is for "pharmaceutical composition".
- Bateman; Simon David - Randolph NJ
| Patent | Date |
|---|---|
| Pharmaceutical composition Grant 9,622,975 - Azria , et al. April 18, 2 | 2017-04-18 |
| 5-CNAC as oral delivery agent for parathyroid hormone fragments Grant 9,272,040 - Azria , et al. March 1, 2 | 2016-03-01 |
| Pharmaceutical Composition App 20150250729 - Azria; Moise ; et al. | 2015-09-10 |
| Use Of Calcitonin In Osteoarthritis App 20140271735 - Azria; Moise ; et al. | 2014-09-18 |
| Use of calcitonin in osteoarthritis Grant 8,765,675 - Azria , et al. July 1, 2 | 2014-07-01 |
| Modified amino acid for the inhibition of platelet aggregation Grant 8,664,211 - Bateman , et al. March 4, 2 | 2014-03-04 |
| 5-cnac As Oral Delivery Agent For Parathyroid Hormone Fragments App 20120088725 - Azria; Moise ; et al. | 2012-04-12 |
| Modified Amino Acid For The Inhibition Of Platelet Aggregation App 20120088833 - BATEMAN; Simon David ; et al. | 2012-04-12 |
| Pharmaceutical Composition App 20110218148 - Azria; Moise ; et al. | 2011-09-08 |
| Use Of Calcitonin In Osteoarthritis App 20100278881 - AZRIA; Moise ; et al. | 2010-11-04 |
| Use of calcitonin in osteoarthritis Grant 7,749,954 - Azria , et al. July 6, 2 | 2010-07-06 |
| 5-cnac As Oral Delivery Agent For Parathyroid Hormone Fragments App 20090264367 - Azria; Moise ; et al. | 2009-10-22 |
| Modified Amino Acid For The Inhibition Of Platelet Aggregation App 20080280817 - Bateman; Simon David ; et al. | 2008-11-13 |
| Pharmaceutical Composition App 20080255048 - Azria; Moise ; et al. | 2008-10-16 |
| Orally Dosed Pharmaceutical Compositions Comprising A Delivery Agent In Micronized Form App 20080234179 - Li; Shoufeng ; et al. | 2008-09-25 |
| Orally Administering Parathyroid Hormone And Calcitonin App 20080119411 - Ault; Joseph M. ; et al. | 2008-05-22 |
| Pharmaceutical composition App 20070231382 - Karnachi; Anees Abdulquadar ; et al. | 2007-10-04 |
| Oral administration of calcitonin App 20070232524 - Azria; Moise ; et al. | 2007-10-04 |
| Pharmaceutical formulations of bisphosphonates App 20070134319 - Zannou; Erika Aina ; et al. | 2007-06-14 |
| Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form App 20070065505 - Li; Shoufeng ; et al. | 2007-03-22 |
| 5-CNAC as oral delivery agent for parathyroid hormone fragments App 20060217313 - Azria; Moise ; et al. | 2006-09-28 |
| Use of calcitonin in osteoarthritis App 20060194722 - Azria; Moise ; et al. | 2006-08-31 |
| Oral administration of calcitonin App 20060135402 - Azria; Moise ; et al. | 2006-06-22 |
| Pharmaceutical compositions for the oral delivery of pharmacologically active agents Grant 7,049,283 - Ault , et al. May 23, 2 | 2006-05-23 |
| Modified amino acid for the inhibition of platelet aggregation App 20060106110 - Bateman; Simon David ; et al. | 2006-05-18 |
| 5-cnac as oral delivery agent for parathyroid hormone fragments App 20040242478 - Azria, Moise ; et al. | 2004-12-02 |
| Method for orally administering parathyroid hormone (pth) App 20040186050 - Ault, Joseph M ; et al. | 2004-09-23 |
| Pharmaceutical composition App 20030114527 - Karnachi, Anees Abdulquadar ; et al. | 2003-06-19 |
| Pharmaceutical compositions for the oral delivery of pharmacologically active agents App 20020123459 - Ault, Joseph M. ; et al. | 2002-09-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 